Amikacin - PubMed (original) (raw)
Book
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
2023 Jul 17.
Affiliations
- PMID: 28613658
- Bookshelf ID: NBK430908
Free Books & Documents
Book
Amikacin
Omeed Sizar et al.
Free Books & Documents
Excerpt
Amikacin is an antimicrobial with activity against more resistant gram-negative bacilli such as Acinetobacter baumanii and Pseudomonas aeruginosa. It also has excellent activity against most aerobic gram-negative bacilli from the Enterobacteriaceae family, including Nocardia sp. and some Mycobacterium spp. (M. avium-intracellulare, M. chelonae, and M. fortuitum). Unlike gentamicin, amikacin does not provide synergistic activity against Enterococcus faecium when combined with beta-lactam antibiotics. This activity covers amikacin, its mechanism, activity spectrum, and its place in an infectious disease regimen. Members of the interprofessional team need to review its indications, coverage, contraindications, and adverse event profile to optimally manage patients with infectious disease.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Disclosure: Omeed Sizar declares no relevant financial relationships with ineligible companies.
Disclosure: Sajedur Rahman declares no relevant financial relationships with ineligible companies.
Disclosure: Vidya Sundareshan declares no relevant financial relationships with ineligible companies.
Sections
- Continuing Education Activity
- Indications
- Mechanism of Action
- Administration
- Adverse Effects
- Contraindications
- Monitoring
- Toxicity
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
Similar articles
- Gram-Negative Bacteria.
Oliveira J, Reygaert WC. Oliveira J, et al. 2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30855801 Free Books & Documents. - Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips.
Manes TJ, DeGenova DT, Taylor BC, Patel JN. Manes TJ, et al. JBJS Essent Surg Tech. 2024 Dec 6;14(4):e23.00094. doi: 10.2106/JBJS.ST.23.00094. eCollection 2024 Oct-Dec. JBJS Essent Surg Tech. 2024. PMID: 39650795 Free PMC article. - Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.
Salisbury L, Baraitser L. Salisbury L, et al. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review. - Immediate Hypersensitivity Reactions (Archived).
Justiz Vaillant AA, Vashisht R, Zito PM. Justiz Vaillant AA, et al. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30020687 Free Books & Documents. - Adenosine Deaminase Deficiency.
Hershfield M, Tarrant T. Hershfield M, et al. 2006 Oct 3 [updated 2024 Mar 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2006 Oct 3 [updated 2024 Mar 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301656 Free Books & Documents. Review.
References
- Endo A, Nemoto A, Hanawa K, Maebayashi Y, Hasebe Y, Kobayashi M, Naito A, Kobayashi Y, Yamamoto S, Isobe K. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants. J Infect Chemother. 2019 Jan;25(1):17-21. - PubMed
- Nolt VD, Pijut KD, Autry EB, Williams WC, Burgess DS, Burgess DR, Arora V, Kuhn RJ. Amikacin target achievement in adult cystic fibrosis patients utilizing Monte Carlo simulation. Pediatr Pulmonol. 2019 Jan;54(1):33-39. - PubMed
- Kulengowski B, Clark JA, Burgess DS. Killing activity of meropenem in combination with amikacin against VIM- or KPC-producing Enterobacteriaceae that are susceptible, intermediate, or resistant to amikacin. Diagn Microbiol Infect Dis. 2019 Apr;93(4):372-375. - PubMed
- Block M, Blanchard DL. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. Jul 17, Aminoglycosides. - PubMed
- Sturkenboom MGG, Simbar N, Akkerman OW, Ghimire S, Bolhuis MS, Alffenaar JC. Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment. Clin Infect Dis. 2018 Nov 28;67(suppl_3):S303-S307. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous